Biolytic Lab Performance, Inc. Joins the International Gene Synthesis Consortium (IGSC)
We are excited to announce that Biolytic Lab Performance, Inc. has officially joined the International Gene Synthesis Consortium (IGSC), a global organization dedicated to advancing safe and ethical gene synthesis practices. As a leader in oligonucleotide synthesis technology, our membership in IGSC reflects our commitment to supporting the responsible innovation and security of synthetic biology.
The IGSC was founded to develop and promote guidelines that protect global health and security by mitigating the risks associated with synthetic gene technology. IGSC members work together to maintain high standards for the synthesis and screening of synthetic gene sequences to prevent misuse. Joining this esteemed group aligns with our core values of building community, efficiency and innovation.
At Biolytic, we understand that the potential of synthetic biology comes with responsibilities. Through IGSC’s programs, we can collaborate with industry leaders, researchers, and policymakers worldwide to contribute to a safe environment for gene synthesis applications. Our role within IGSC will allow us to further support our customers, as they pursue groundbreaking research and development in life sciences, pharmaceuticals, and beyond.
As we take on this new responsibility, we’re committed to maintaining transparency and accountability in our practices. Our continued dedication to innovation, paired with IGSC’s guidance, will ensure that Biolytic Lab Performance remains at the forefront of safe, reliable oligonucleotide synthesis technology. We look forward to the new opportunities this partnership will bring to our community, and we are proud to be a part of the future of responsible gene synthesis.
For more information about IGSC and its mission, please visit IGSC’s official website.
